Business Insider: Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults Healthline: Some IBS Treatments May Be Linked to Slightly Higher Risk of Early Death Some IBS Treatments May Be Linked to Slightly Higher Risk of Early Death Yahoo: IBS is more common than many realize. Here's how these treatments can help. IBS is more common than many realize.

Understanding the Context

Here's how these treatments can help. Outlook India: Some IBS Treatments Linked To Higher Mortality Risk, Study Finds Treatment for irritable bowel syndrome, IBS, often includes restricting certain foods, such as carbohydrates, but that doesn’t work for everyone. A new study has found that there might be a genetic ...